Form 4 for DMAC DiaMedica Therapeutics Inc.
Accepted 2021-09-15 00:00:00 ET · period of report 2021-09-15 · accession 0001235802-21-000119 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-09-15 | 2021-09-15 | DMAC | ALCORN HARRY W JR | SVP, Clinical Ops | P - Purchase | $3.80 | +15.0K | 43.6K | +52% | +$57.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Voting Common Shares, no par value per share | 2021-09-15 | P | A | 15,000 | $3.80 | 43,582 | D | — | — |